Aeglea BioTherapeutics brings Dr. Bryan Lawlis on Board

World |  News | 0 Comment | 17 Jul, 2018

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company that designs and develops innovative human en...Read more

RGN-259 (Tβ4) better improves Dry Eye Syndrome

World |  News | 0 Comment | 17 Jul, 2018

RegeneRx Biopharmaceuticals, or "RegeneRx", a clinical-stage drug development company focused on tissue protection, repa...Read more

New ALS therapy in clinical trials

World |  News | 0 Comment | 17 Jul, 2018

About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...Read more

NCP invests in Firma Clinical Research

World |  News | 0 Comment | 17 Jul, 2018

Northlane Capital Partners has announced that it has made an investment in Firma Clinical Research (“Firma”)...Read more

NeuroTrauma, Henry Ford announce research and license agreements

World |  News | 0 Comment | 16 Jul, 2018

Singapore – NeuroTrauma Sciences, a biopharmaceutical company, and Henry Ford Health System, a non-profi...Read more

FDA approves first drug indicating treatment of smallpox

World |  News | 0 Comment | 16 Jul, 2018

 Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug wit...Read more

NuVasive launches next-gen spinal fusion system

World |  News | 0 Comment | 16 Jul, 2018

 Singapore – NuVasive announces the commercial launch of its next-evolution Reline system...Read more

Hancock Jaffe appoints new CFO

World |  News | 0 Comment | 16 Jul, 2018

Singapore – Hancock Jaffe Laboratories, a company specializing in bioprosthetic medical devices to estab...Read more

Clementia appoints Steve Forte as CFO

World |  News | 0 Comment | 13 Jul, 2018

Singapore – Clementia Pharmaceuticals, a clinical-stage biopharmaceutical company innovating new treatments for pe...Read more

X4 Pharma appoints Michael Wyzga as Chair of Board of Directors

World |  News | 0 Comment | 13 Jul, 2018

X4 Pharmaceuticals, a clinical-stage biotechnology company developing novel CXCR4 allosteric antagonist drug candidates ...Read more

Accenture named a leader in Life Sciences R&D BPO Services

World |  News | 0 Comment | 13 Jul, 2018

Accenture has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process ...Read more

Abbott gets FDA consent for Next-Gen MitraClip Device

World |  News | 0 Comment | 13 Jul, 2018

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leadi...Read more

Immatics, Genmab to develop bispecific cancer immunotherapies

World |  News | 0 Comment | 12 Jul, 2018

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-c...Read more

Qiagen to expand biomarker research in UK

World |  News | 0 Comment | 12 Jul, 2018

Qiagen has announced a partnership with multiple organizations to support creating a global genomics campus in Mancheste...Read more

New wearable patch to detect heart ailments

World |  News | 0 Comment | 11 Jul, 2018

Researchers have found a wearable patch that acts like a sensor can effectively improve the diagnosis rate for heart rhy...Read more

Thermo Fisher to aid researchers by publishing antibody data

World |  News | 0 Comment | 11 Jul, 2018

Thermo Fisher Scientific has signed an agreement with reagent intelligence platform BenchSci to use its trademarked mach...Read more

Duke University collaborates with Microsoft for research

World |  News | 0 Comment | 11 Jul, 2018

Duke University has announced a new collaboration with Microsoft in several areas including research and cognitive servi...Read more

Cellect enters into strategic agreement with Swiss Biotech Centre

World |  News | 0 Comment | 10 Jul, 2018

Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced that it has entered into a...Read more